McCann has today announced that TherapeuticsMD, Inc. (NASDAQ: TXMD) has selected McCann as the agency of record for Annovera - a first-of-its kind, FDA-approved female contraceptive.
“We are excited to work with McCann as we bring Annovera to the market,” said Dawn Halkuff, chief commercial officer, TherapeuticsMD, Inc., Boca Raton, FL. “TXMD is confident that this partnership will continue to help us break down barriers and drive transformational change by championing awareness and treatment of women’s healthcare issues.”
The account assignment for McCann, which follows a competitive pitch, will include brand strategy, creative development and execution for the contraceptive.
“Annovera not only has the potential to change the female reproductive category, but has an ambition to change how modern women are marketed to.” said Devika Bulchandani, president of McCann New York. “We are honored to be named as agency of record, and help empower women to be in control of their reproductive decisions.”